InvestorsHub Logo
Followers 74
Posts 15841
Boards Moderated 0
Alias Born 04/26/2010

Re: Chris2125 post# 219468

Tuesday, 10/15/2019 2:13:30 PM

Tuesday, October 15, 2019 2:13:30 PM

Post# of 425627

NAFLD is an exploratory sub-group set of analyses in REDUCE-IT from baseline to end



Don't know where he got that - it's not listed as a tertiary endpoint. And diagnosing NAFLD requires an ultrasound or Fibroscan - no way AMRN did those on R-IT patients, the clinics running the trial wouldn't have the equipment - only diagnostic imaging facilities have those machines, they're not cheap, and you need a radiologist to evaluate the scans.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News